Title |
Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor‑1
|
---|---|
Published in |
Journal of Medicinal Chemistry, March 2018
|
DOI | 10.1021/acs.jmedchem.8b00170 |
Pubmed ID | |
Authors |
Thomas Durek, Philipp M. Cromm, Andrew M. White, Christina I. Schroeder, Quentin Kaas, Joachim Weidmann, Abdullah Ahmad Fuaad, Olivier Cheneval, Peta J. Harvey, Norelle L. Daly, Yang Zhou, Anita Dellsén, Torben Österlund, Niklas Larsson, Laurent Knerr, Udo Bauer, Horst Kessler, Minying Cai, Victor J. Hruby, Alleyn T. Plowright, David J. Craik |
Abstract |
Ultra-stable cyclic peptide frameworks offer great potential for drug design due to their improved bioavailability compared to their linear analogues. Using the sunflower trypsin inhibitor-1 (SFTI-1) peptide scaffold in combination with systematic N-methylation of the grafted pharmacophore led to the identification of novel subtype selective melanocortin receptor (MCR) agonists. Multiple bicyclic peptides were synthesized and tested towards their activity at MC1R and MC3-5R. Double N-methylated compound 18 showed a pKi of 8.73±0.08 (Ki = 1.92±0.34 nM) and a pEC50 of 9.13±0.04 (EC50 = 0.75±0.08 nM) at the human MC1R and was over 100 times more selective for MCR1. NMR structural analysis of 18 emphasized the role of peptide bond N-methylation in shaping the conformation of the grafted pharmacophore. More broadly, this study highlights the potential of cyclic peptide scaffolds for epitope grafting in combination with N-methylation to introduce receptor subtype selectivity in the context of peptide-based drug discovery. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 24% |
Student > Ph. D. Student | 9 | 24% |
Student > Master | 6 | 16% |
Student > Postgraduate | 2 | 5% |
Lecturer | 1 | 3% |
Other | 2 | 5% |
Unknown | 8 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 13 | 35% |
Biochemistry, Genetics and Molecular Biology | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
Medicine and Dentistry | 3 | 8% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 3 | 8% |
Unknown | 10 | 27% |